Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations-Reference-Cited by-同舟云学术

Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations

Published:2017-03-01 Issue:2 Volume:37 Page:97-107
ISSN:2234-3806
Container-title:Annals of Laboratory Medicine
language:en
Short-container-title:Ann Lab Med

Author:

Choi Rihwa¹,Jeong Byeong-Ho²,Koh Won-Jung²,Lee Soo-Youn¹³

Affiliation:

1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

3. Department of Clinical Pharmacology & Therapeutics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Funder

Ministry of Health and Welfare

Publisher

Annals of Laboratory Medicine

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3343/alm.2017.37.2.97

Reference82 articles.

1. WHO. Global tuberculosis report 2016. WHO/HTM/TB/2015.22. Geneva. World Health Organization. 2016. Accessed on Nov 2016. http://www.who.int/tb/publications/global_report/en/

2. Treatment of Drug Susceptible Pulmonary Tuberculosis

3. Treatment of Tuberculosis

4. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of NAT2 Genotypes in a Cohort of Patients with Suspected TB in the State of Rio de Janeiro;Pharmaceutics;2024-07-10

2. Nutritional Indices Predict All Cause Mortality in Patients with Multi-/Rifampicin-Drug Resistant Tuberculosis;Infection and Drug Resistance;2024-07

3. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

4. Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine;Molecules;2024-01-09

5. Pharmacokinetic assessment of rifampicin and des-acetyl rifampicin in carbon tetrachloride induced liver injury model in Wistar rats;Journal of Complementary and Integrative Medicine;2023-12-25